Physician profile
Satyendra P Singh
NPI 1811907108
$1,340.69
in general payments reported to CMS, 2019-2025
18 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $201 · 2021: $124 · 2022: $311 · 2023: $184 · 2024: $164 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $401.16 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $161.36 | 2020-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $112.01 | 2021-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $85.53 | 2019-2024 | Jot Dx |
| Novartis Pharmaceuticals Corporation | $80.64 | 2019-2022 | |
| Lilly USA, LLC | $69.99 | 2020-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.93 | 2020-2025 | Jardiance |
| Exact Sciences Corporation | $50.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Heartflow, INC. | $48.55 | 2019 | |
| Radius Health, INC. | $45.74 | 2023-2025 | |
| Boston Scientific Corporation | $31.40 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.44 | 2024-2025 | |
| Pfizer INC. | $29.27 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $27.77 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.43 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.70 | 2022 | |
| Daiichi Sankyo INC. | $24.47 | 2020 | |
| Dexcom, INC. | $21.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satyendra Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.